丙酸睪酮/庚酸睪酮/十一烯酸睪酮

丙酸睪酮/庚酸睪酮/十一烯酸睪酮
組成
丙酸睪酮	雄激素、合成代謝類固醇
庚酸睪酮	雄激素、合成代謝類固醇
十一烯酸睪酮	雄激素、合成代謝類固醇
臨床資料
商品名（英語：Drug nomenclature）	Durasteron
其他名稱	TP/TE/TUe
給藥途徑	肌肉注射

丙酸睪酮/庚酸睪酮/十一烯酸睪酮，簡稱TP/TE/TUe，以商品名Durasteron出售，是丙酸睪酮（TP）、庚酸睪酮（TV）和十一烯酸睪酮（TUe）的注射複方藥，它們都是雄激素/合成代謝類固醇。^[1]^[2]它是一種油溶液，含有20毫克TP、80毫克TE和150毫克TUe（總共250毫克睪酮酯和169.5毫克游離睪酮），並通過定期肌肉注射給藥，例如每3或4周一次。^[3]^[4]^[5]據報道，部分健美運動員使用Durasteron。^[1]^[2]

參見

參考資料

^ ^1.0 ^1.1 Daher EF, Silva Júnior GB, Queiroz AL, Ramos LM, Santos SQ, Barreto DM, et al. Acute kidney injury due to anabolic steroid and vitamin supplement abuse: report of two cases and a literature review. International Urology and Nephrology. 2009, 41 (3): 717–23. PMID 19387860. S2CID 23319246. doi:10.1007/s11255-009-9571-8.
^ ^2.0 ^2.1 Davani-Davari D, Karimzadeh I, Khalili H. The potential effects of anabolic-androgenic steroids and growth hormone as commonly used sport supplements on the kidney: a systematic review. BMC Nephrology. May 2019, 20 (1): 198. PMC 6545019 . PMID 31151420. doi:10.1186/s12882-019-1384-0 .
^ Joël, Charles A. Zur Behandlung männlicher Fertilitätsstörungen mit hohen Androgendosen [For the treatment of male fertility disorders with high androgen doses]. Gynecologic and Obstetric Investigation. 1960, 150 (3): 149–156. ISSN 1423-002X. doi:10.1159/000305737. [...] 20 mg Testosteronpropionat, 80 mg Testosteronheptanoat, 150 mg Testosteronundecylat (Durasteron Teva) [...]
^ Arends G, Zörnig H, Hager H, Frerichs G, Kern W. Hagers Handbuch der pharmazeutischen Praxis: Für Apotheker, Arzneimittelhersteller, Drogisten, Ärzte u. Medizinalbeamte. Springer-Verlag. 14 December 2013: 1145–. ISBN 978-3-662-36329-4. At the same time, treatment with a long-acting testosterone preparation (Durasteron®) was instituted, with one injection given every four weeks.
^ Spitz IM, Hirsch HJ, Landau H, Zylber-Haran E, Gross V, Rachmilewitz EA. TSH secretion in thalassemia. Journal of Endocrinological Investigation. October 1984, 7 (5): 495–9. PMID 6439771. S2CID 20319052. doi:10.1007/BF03348456. The male patients were given a long acting tes- tosterone preparation (Durasteron, Teva) 250 mg by im injection every 3 weeks for a total of 8 injections.

[DaherSilva_Júnior2009-1] 1.0 ^1.1 Daher EF, Silva Júnior GB, Queiroz AL, Ramos LM, Santos SQ, Barreto DM, et al. Acute kidney injury due to anabolic steroid and vitamin supplement abuse: report of two cases and a literature review. International Urology and Nephrology. 2009, 41 (3): 717–23. PMID 19387860. S2CID 23319246. doi:10.1007/s11255-009-9571-8.

[Davani-DavariKarimzadeh2019-2] 2.0 ^2.1 Davani-Davari D, Karimzadeh I, Khalili H. The potential effects of anabolic-androgenic steroids and growth hormone as commonly used sport supplements on the kidney: a systematic review. BMC Nephrology. May 2019, 20 (1): 198. PMC 6545019 . PMID 31151420. doi:10.1186/s12882-019-1384-0 .

[Joël1960-3] Joël, Charles A. Zur Behandlung männlicher Fertilitätsstörungen mit hohen Androgendosen [For the treatment of male fertility disorders with high androgen doses]. Gynecologic and Obstetric Investigation. 1960, 150 (3): 149–156. ISSN 1423-002X. doi:10.1159/000305737. [...] 20 mg Testosteronpropionat, 80 mg Testosteronheptanoat, 150 mg Testosteronundecylat (Durasteron Teva) [...]

[ArendsZörnig2013-4] Arends G, Zörnig H, Hager H, Frerichs G, Kern W. Hagers Handbuch der pharmazeutischen Praxis: Für Apotheker, Arzneimittelhersteller, Drogisten, Ärzte u. Medizinalbeamte. Springer-Verlag. 14 December 2013: 1145–. ISBN 978-3-662-36329-4. At the same time, treatment with a long-acting testosterone preparation (Durasteron®) was instituted, with one injection given every four weeks.

[SpitzHirsch2014-5] Spitz IM, Hirsch HJ, Landau H, Zylber-Haran E, Gross V, Rachmilewitz EA. TSH secretion in thalassemia. Journal of Endocrinological Investigation. October 1984, 7 (5): 495–9. PMID 6439771. S2CID 20319052. doi:10.1007/BF03348456. The male patients were given a long acting tes- tosterone preparation (Durasteron, Teva) 250 mg by im injection every 3 weeks for a total of 8 injections.

[1]

[2]

[3]

[4]

[5]